We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Tolerability of the soybeverage and compliance were assessed.
2
Mean consumption of the assigned soybeverage was 93%.
3
Our objective was to evaluate the tolerability and effect of a daily soybeverage in prostate cancer patients with biochemical failure after radiotherapy.
4
Patients with rising prostate-specific antigen (PSA) after radical radiation for prostate cancer were instructed to consume 500 ml of soybeverage daily for 6 mo.